🇺🇸 FDA
Patent

US 10590074

Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

granted A61KA61K31/135A61K45/06

Quick answer

US patent 10590074 (Potent and selective inhibitors of monoamine transporters; method of making; and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/135, A61K45/06, A61P, A61P25/00